In the subgroup of patients with luminal B BC, the combined analysis increased the SE and NPV of the tests, reaching the highest value of 100% for both features for the combination of CXCL1 + CXCL8 + CA 15-3. The gene discussed is CXCL1; the disease is breast cancer.